483 related articles for article (PubMed ID: 29968329)
41. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Amlani B; Elsayed G; Barvalia U; Kanne JP; Meyer KC; Sandbo N; Li Z; McCoy SS
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):136-147. PubMed ID: 33093777
[TBL] [Abstract][Full Text] [Related]
42. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
43. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
44. Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria.
Bartůnková J; Sedivá A; Vencovský J; Tesar V
Clin Exp Rheumatol; 1999; 17(3):381-6. PubMed ID: 10410277
[TBL] [Abstract][Full Text] [Related]
45. Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
Dong X; Gao YL; Lu Y; Zheng Y
Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
[TBL] [Abstract][Full Text] [Related]
47. Anti-SSA/SSB-negative primary Sjögren's syndrome showing different clinical phenotypes: a retrospective study of 934 cases.
Chen J; He Q; Yang J; Wu T; Huang Z; Zhang Y; Liao J; Zhang L; Yu X; Yao C; Luo J; Tao Q
Adv Rheumatol; 2023 May; 63(1):21. PubMed ID: 37189182
[TBL] [Abstract][Full Text] [Related]
48. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
Bak E; Yang HK; Hwang JM
Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
[TBL] [Abstract][Full Text] [Related]
49. Risk factors and prognosis of interstitial lung disease for primary Sjögren syndrome patients: A retrospective case‒control study.
Huang Y; Qiu Y; Xie Z; Zhang F; Zhang Y; Guan M; Wang X; Cai W; Sun J
Clin Rheumatol; 2023 Nov; 42(11):3033-3041. PubMed ID: 37421537
[TBL] [Abstract][Full Text] [Related]
50. Characteristics and mortality in primary Sjögren syndrome-related interstitial lung disease.
Gao H; Sun Y; Zhang XY; Xie L; Zhang XW; Zhong YC; Zhang J; Hou YK; Li ZG
Medicine (Baltimore); 2021 Sep; 100(35):e26777. PubMed ID: 34477117
[TBL] [Abstract][Full Text] [Related]
51. Active immunological profile is associated with systemic Sjögren's syndrome.
Martel C; Gondran G; Launay D; Lalloué F; Palat S; Lambert M; Ly K; Loustaud-Ratti V; Bezanahary H; Hachulla E; Jauberteau MO; Vidal E; Hatron PY; Fauchais AL
J Clin Immunol; 2011 Oct; 31(5):840-7. PubMed ID: 21744183
[TBL] [Abstract][Full Text] [Related]
52. Interstitial lung disease in Primary Sjögren's syndrome.
Lin W; Xin Z; Zhang J; Liu N; Ren X; Liu M; Su Y; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Li J; Xue H; Niu N; Chen Y; Li F; Sun L; Zhang X; Zhang F; Zhang W
BMC Pulm Med; 2022 Feb; 22(1):73. PubMed ID: 35220958
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
54. Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome.
Palm Ø; Ueland T; Garen T; Michelsen AE; Reiseter S; Aukrust P; Aaløkken TM; Molberg Ø
Clin Exp Rheumatol; 2016; 34(4):690-3. PubMed ID: 27214260
[TBL] [Abstract][Full Text] [Related]
55. Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren's syndrome.
Kakugawa T; Sakamoto N; Ishimoto H; Shimizu T; Nakamura H; Nawata A; Ito C; Sato S; Hanaka T; Oda K; Kido T; Miyamura T; Nakashima S; Aoki T; Nakamichi S; Obase Y; Saito K; Yatera K; Ishimatsu Y; Nakayama T; Korogi Y; Kawakami A; Tanaka Y; Mukae H
Respir Med; 2018 Apr; 137():95-102. PubMed ID: 29605220
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary manifestations of childhood-onset primary Sjogren's syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS.
Bartholomeo A; Aujla S; Eklund M; Kerrigan C; Riemer E; Gilbert M
Pediatr Rheumatol Online J; 2022 Nov; 20(1):101. PubMed ID: 36384806
[TBL] [Abstract][Full Text] [Related]
58. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
[TBL] [Abstract][Full Text] [Related]
59. Lung Involvement in Primary Sjögren's Syndrome-An Under-Diagnosed Entity.
Sogkas G; Hirsch S; Olsson KM; Hinrichs JB; Thiele T; Seeliger T; Skripuletz T; Schmidt RE; Witte T; Jablonka A; Ernst D
Front Med (Lausanne); 2020; 7():332. PubMed ID: 32766261
[TBL] [Abstract][Full Text] [Related]
60. Assessment of interstitial lung disease in Sjögren's syndrome by lung ultrasound: a pilot study of correlation with high-resolution chest tomography.
Vasco PG; de Luna Cardenal G; Garrido IM; Pinilla JM; Rodríguez GF; Mateo JJ; Ruiz DC
Intern Emerg Med; 2017 Apr; 12(3):327-331. PubMed ID: 27900604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
